Nam Yunsung, Wie Myung Bok, Shin Eun-Joo, Nguyen Thuy-Ty Lan, Nah Seung-Yeol, Ko Sung Kwon, Jeong Ji Hoon, Jang Choon-Gon, Kim Hyoung-Chun
Neuropsychopharmacology and Toxicology Program, College of Pharmacy, Kangwon National University, Chunchon, 200-701, Republic of Korea.
School of Veterinary Medicine, Kangwon National University, Chunchon, 200-701, Republic of Korea.
J Appl Toxicol. 2015 Aug;35(8):927-44. doi: 10.1002/jat.3093. Epub 2014 Dec 18.
Recently, we have demonstrated that ginsenoside Re protects methamphetamine (MA)-induced dopaminergic toxicity in mice via genetic inhibition of PKCδ and attenuation of mitochondrial stress. In addition, we have reported that induction of mitochondrial glutathione peroxidase (GPx) is also important for neuroprotection mediated by ginsenoside Re. To extend our knowledge, we examined the effects of ginsenoside Re against MA toxicity in vitro condition using SH-SY5Y neuroblastoma cells. Treatment with ginsenoside Re resulted in significant attenuations against a decrease in the activity of GPx and an increase in the activity of superoxide dismutase (SOD) in the cytosolic and mitochondrial fraction. The changes in glutathione (GSH) paralleled those in GPx in the same experimental condition. Consistently, ginsenoside Re treatment exhibited significant protections against cytosolic and mitochondrial oxidative damage (i.e. lipid peroxidation and protein oxidation), mitochondrial translocation of PKCδ, mitochondrial dysfunction (mitochondrial transmembrane potential and intra-mitochondrial Ca(2+)), apoptotic events [i.e., cytochrome c release from mitochondria, cleavage of caspase-3 and poly(ADP-ribose)polymerase-1, nuclear condensation, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL)-positive apoptotic cells], and a reduction in the tyrosine hydroxylase (TH) expression and TH activity induced by MA in SH-SY5Y neuroblastoma cells. These protective effects of ginsenoside Re were comparable to those of PKCδ antisense oligonucleotide (ASO). However, ginsenoside Re did not significantly provide additional protective effects mediated by genetic inhibition of PKCδ. Our results suggest that PKCδ is a specific target for ginsenoside Re-mediated protective activity against MA toxicity in SH-SY5Y neuroblastoma cells.
最近,我们已经证明人参皂苷Re通过对蛋白激酶Cδ(PKCδ)的基因抑制和线粒体应激的减轻来保护小鼠免受甲基苯丙胺(MA)诱导的多巴胺能毒性。此外,我们还报道了线粒体谷胱甘肽过氧化物酶(GPx)的诱导对于人参皂苷Re介导的神经保护也很重要。为了进一步拓展我们的认识,我们使用SH-SY5Y神经母细胞瘤细胞在体外条件下研究了人参皂苷Re对MA毒性的影响。用人参皂苷Re处理导致细胞溶质和线粒体部分中GPx活性的降低以及超氧化物歧化酶(SOD)活性的增加得到显著减轻。在相同实验条件下,谷胱甘肽(GSH)的变化与GPx的变化平行。一致地,人参皂苷Re处理对细胞溶质和线粒体氧化损伤(即脂质过氧化和蛋白质氧化)、PKCδ的线粒体易位、线粒体功能障碍(线粒体跨膜电位和线粒体内Ca(2+))、凋亡事件[即细胞色素c从线粒体释放、半胱天冬酶-3和聚(ADP-核糖)聚合酶-1的切割、核浓缩、末端脱氧核苷酸转移酶介导的dUTP缺口末端标记(TUNEL)阳性凋亡细胞]以及MA诱导的SH-SY5Y神经母细胞瘤细胞中酪氨酸羟化酶(TH)表达和TH活性的降低均表现出显著的保护作用。人参皂苷Re的这些保护作用与PKCδ反义寡核苷酸(ASO)的保护作用相当。然而,人参皂苷Re并未显著提供由PKCδ基因抑制介导的额外保护作用。我们的结果表明,PKCδ是人参皂苷Re介导的针对SH-SY5Y神经母细胞瘤细胞中MA毒性的保护活性的特定靶点。